Literature DB >> 36147245

The Case for Moxibustion for Painful Syndromes: History, principles and rationale.

Nigel C Dawes1, Joyce K Anastasi2.   

Abstract

Traditional Chinese Medicine (TCM) has evolved over thousands of years. TCM practitioners use various approaches (such as acupuncture and tai chi) as well as herbal products to address health problems. Though lesser known in the west, the practice of Moxibustion is an integral part of Traditional East Asian Medicine. Moxibustion is an important non-invasive treatment that has shown to be beneficial in treating painful syndromes including neuropathy. It has been suggested that moxibustion may alleviate neuroinflammation by inhibiting NF-kB and by activating Nrf2. These anti-inflammatory and protective mechanisms could be key to exploring the use of moxibustion in treating other etiologies of neuropathy including HIV. There is ample scope for future study in this area and consideration of the history, development and practical applications of moxibustion therapy may be of help in this regard. This article seeks to explore the background, principles, and application of moxibustion in the clinical setting with particular emphasis on its potential for symptom management in the treatment of neuropathy and pain.

Entities:  

Year:  2022        PMID: 36147245      PMCID: PMC9491495          DOI: 10.29011/2577-2201.100053

Source DB:  PubMed          Journal:  Curr Res Compliment Altern Med        ISSN: 2577-2201


  37 in total

1.  The role of the sympathetic nervous system in moxibustion-induced immunomodulation in rats.

Authors:  Jae Bok Han; Sang-Duck Oh; Ki-Seok Lee; Ki-Soon Choi; Young-Wuk Cho; Hyun -ong Ahn; Hyunsu Bae; Byung-Il Min
Journal:  J Neuroimmunol       Date:  2003-07       Impact factor: 3.478

2.  [Observation on the therapeutic effect of painless festering moxibustion on knee osteoarthritis].

Authors:  Yong Fu; Ming-fei Kang; Ri-xin Chen; Bo Zhang; Hai-feng Zhang
Journal:  Zhongguo Zhen Jiu       Date:  2007-07

3.  [Clinical observation on treatment of primary knee osteoarthritis of liver and kidney deficiency type with Aconite cake-separated moxibustion].

Authors:  Kui Sun; Jun Yang; De-Kai Shen
Journal:  Zhongguo Zhen Jiu       Date:  2008-02

4.  Heat-sensitive moxibustion for lumbar disc herniation: a meta-analysis of randomized controlled trials.

Authors:  Rixin Chen; Jun Xiong; Zhenhai Chi; Bo Zhang
Journal:  J Tradit Chin Med       Date:  2012-09       Impact factor: 0.848

5.  Diverse biological activities of moxa extract and smoke.

Authors:  N Hitosugi; R Ohno; I Hatsukari; S Mizukami; H Nagasaka; I Matsumoto; N Komatsu; M Fujimaki; H Nakashima; K Satoh; H Sakagami
Journal:  In Vivo       Date:  2001 May-Jun       Impact factor: 2.155

Review 6.  Moxibustion for treating pain: a systematic review.

Authors:  Myeong Soo Lee; Tae-Young Choi; Jung Won Kang; Beom-Joon Lee; Edzard Ernst
Journal:  Am J Chin Med       Date:  2010       Impact factor: 4.667

7.  Curative effect of heat-sensitive moxibustion on chronic persistent asthma: a multicenter randomized controlled trial.

Authors:  Rixin Chen; Mingren Chen; Jun Xiong; Zhenhai Chi; Bo Zhang; Ning Tian; Zhenhua Xu; Tangfa Zhang; Wanyao Li; Wei Zhang; Xiaofeng Rong; Zhen Wang; Gang Sun; Baohe Ge; Guoxiong Yu; Nanchang Song
Journal:  J Tradit Chin Med       Date:  2013-10       Impact factor: 0.848

8.  Does moxibustion work? An overview of systematic reviews.

Authors:  Myeong Soo Lee; Jung Won Kang; Edzard Ernst
Journal:  BMC Res Notes       Date:  2010-11-05

9.  Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial.

Authors:  Mingxiao Yang; Xiangzhu Chen; Linna Bo; Lixing Lao; Jiao Chen; Siyi Yu; Zheng Yu; Hongzhi Tang; Ling Yi; Xi Wu; Jie Yang; Fanrong Liang
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

10.  Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy.

Authors:  Jia Li; Xia Hu; Fengxia Liang; Jianmin Liu; Huanjiao Zhou; Jiaoping Liu; Hua Wang; Hongtu Tang
Journal:  Appl Biochem Biotechnol       Date:  2019-06-17       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.